LX9211, an Orally-Administered, Non-opioid, AAK1 Inhibitor for Painful Diabetic Peripheral Neuropathy-Results from a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study
用户kBdX2vZ_nP3w
25天前
41
10
已关闭
DOI:
文献链接:
其他信息: